DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160310

Endoscopic early detection of premalignant changes in stomach with mucosal biopsy in patients with symptomatology of acid peptic disease

Ajay A. Gujar, Geeta A. Gujar

Abstract


Background: Stomach cancer is the second-most common cancer among men and third-most among females in Asia and worldwide. The symptoms and sign of the stomach cancer are often reported late when the disease is already in advanced stages and 5-year survival is less than 30% in developed countries and around 20% in developing countries. Early detection of cancer stomach is still remains challenge to the gastroenterologist.

Methods: This study was done to detect early premalignant changes by upper GI scopy and histopathological examinations of mucosal biopsies in patients with symptoms of acid peptic disease not responding to any type of medications. 200 patients above 20 years of age with acid peptic disease symptoms selected for upper GI scopy and histopathology with follow up from 6 months to two years to detect whether premalignant lesion changes to malignancy.

Results: Different types of inflammatory lesions of gastric mucosa detected endoscopically and on histopathology in our study. In 7 patients premalignant changes were detected and 7 patients already had gross malignancies in stomach. Out of the total number of biopsies included in the study, we observed lesions of atrophic type in 4 antral biopsies (2.25%) and 3 biopsies of the gastric body (1.69%). All were grade 1 as per Sydney classification.

Conclusions: Upper endoscopy with histopathology has excellent output to detect early premalignant changes in stomach mucosa, though it is long way to continue this study to correlate both.


Keywords


Endoscopic biopsy, Premalignant lesions of stomach cancer, Gastritis, Atrophic gastritis

Full Text:

PDF

References


Ferlay J, Bray F, Forman D. Globocan. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10, Lyon. 2010.

Onodera H, Tokunaga A, Yoshiyuki T. Surgical oucome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer. Hepato gastroenterology. 2004 51:82-5.

Tan YK, Fielding JW. Early diagnosis of early gastric cancer. Eur Gastroenterol Hepatol. 2006;18:821-9.

Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554-60.

De Vries AC, Van Grieken NC, Looman CW. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Nederlands Gastroenterology. 2008;134:945-52. Gastric Carcinoma- New Insights into Current Management.

Taghavi SA, Membari ME, Eshraghian A. Comparison of chromoendoscopy and conventional endoscopy in the detection of premalignant gastric lesions. Can J Gastroenterol. 2009;23(2):105-8.

Ida K, Hashimoto Y, Takeda S. Endoscopic diagnosis of gastric cancer with dye scattering. Am J Gastroenterol. 1975;63:316-20.

Tytgat GNJ. The Sydney System: Endoscopic Division. Endoscopic appearances in gastritis/duodenitis. J Gastro enteral Hepatol. 1991;6:223-34.

Price AB. The Sydney System: histological division. J Gastro enteral Hepatol. 1991;6:209-22.

Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the histopathology of gastritis, Houston, 1994. Am J Surg Pathol. 1996;20:1161-81.

Kaur G, Raj M. A study of the concordance between endoscopic gastritis and histological gastritis in an area with a low background prevalence of Helicobacter pylori infection. Singapore Med J. 2002;43(2):90-2.

Sipponen P, Kekki M, Siurala M. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer. 1983;52:1062-8.

Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ. 2004;157:301-10.

Genta RM, Rugge M. Assessing risks for gastric cancer: new tools for pathologists. World J Gastroenterol. 2006;12(35):5622-7.

Thamaki T, Saukkonen M, Siurala M. The sequelae and course of chronic gastritis during 30+ to 34+zear bioptic follow-up study. Scand J Gastroenterol. 1985;20:485-91.

Correa P. Chronic gastritis as a cancer precursor. Scand J Gastro enteral suppl. 1984;104:131-6.

Marshall BJ, Warren JR. Unidentified curved bacilli in the stomachof patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-5.

Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-40.

Schlemper RJ, Riddel RH, Kato Y. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251-5.

Rugge M, Correa P, Dixon MF. Gastric dysplasia: the Padova international classification.Am J Surg Pathol. The Role of Endoscopy and Biopsy in Evaluating Preneoplastic and Particular Gastric Lesions. 2000;24:167-76.

Rugge M, Correa P, Dixon MF. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther. 2002:16:1249-59.

Ruiz B, Garay J, Johnson W, Li D. Morphometric assessment of gastric antral atrophy: comparison with visual evaluation. Histopathology. 2001;39:235-42.

Thamaki T, Sipponen P, Varis K. Characteristics of gastric mucosa which precede occurrence gastric malignancy: results of long-term follow-up of three family samples. Scand J Gastroenterology. 1991;186:16-23.

Correa P. Helicobacter pylori and gastric cancer. state of the art. Cancer Epidemiol Biomarkers Prev. 1996;5:477-81.

Abrams JA, Wang TC. Adenocarcinoma and other tumors of the stomach. In Gastrointestinal and Liver Disease, Saunders, Elsevier. 2010;1:887-904.

Lahner E, Bordi C, Cattaruzza MS. Long-term follow-up in atrophic body gastritis patients: Atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005;22:471-81.

De Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter. 2007;12:1-15.

Cassaro M, Rugge M, Gutierrez O. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431-8.

Cassaro M, Rugge M, Gutierrez O. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431-8.

Asaka M, Sugiyama T, Nobuta A. Atrophic gastritis and intestinal metaplasia in Japan: Results of a large multicenter study. Helicobacter. 2001;6:294-9.

Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin Active participant or bystander in gastric carcinogenesis?. Nat Rev Cancer. 2006;6:936-46.

Yang JM, Chen L, Fan YL. Endoscopic patterns of gastric mucosa and its clinic pathological significance. World J Gastroenterol. 2003;9(11):2552-6.

El-Zimaity HM, Ota H, Graham DZ. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer. 2002;94:1428-36.